155 related articles for article (PubMed ID: 8375853)
1. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.
Bostwick DG; Srigley J; Grignon D; Maksem J; Humphrey P; van der Kwast TH; Bose D; Harrison J; Young RH
Hum Pathol; 1993 Aug; 24(8):819-32. PubMed ID: 8375853
[TBL] [Abstract][Full Text] [Related]
2. Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma.
Montironi R; Bartels PH; Hamilton PW; Thompson D
Hum Pathol; 1996 Apr; 27(4):396-407. PubMed ID: 8617484
[TBL] [Abstract][Full Text] [Related]
3. Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.
Lopez-Beltran A; Qian J; Montironi R; Luque RJ; Bostwick DG
Int J Surg Pathol; 2005 Apr; 13(2):167-73. PubMed ID: 15864380
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.
Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z
Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160
[TBL] [Abstract][Full Text] [Related]
5. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies.
Bostwick DG; Qian J
Am J Surg Pathol; 1995 May; 19(5):506-18. PubMed ID: 7537024
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
7. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
Botticelli AR
Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
[TBL] [Abstract][Full Text] [Related]
8. Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations.
Devaraj LT; Bostwick DG
Am J Surg Pathol; 1993 Jul; 17(7):645-59. PubMed ID: 7686348
[TBL] [Abstract][Full Text] [Related]
9. Mucin expression in atypical adenomatous hyperplasia of the prostate.
Goldstein NS; Qian J; Bostwick DG
Hum Pathol; 1995 Aug; 26(8):887-91. PubMed ID: 7543443
[TBL] [Abstract][Full Text] [Related]
10. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
[TBL] [Abstract][Full Text] [Related]
11. [Benign microglandular prostate lesions. Diagnostic criteria na differential diagnosis].
Bonkhoff H; Remberger K
Pathologe; 1998 Jan; 19(1):1-11. PubMed ID: 9541937
[TBL] [Abstract][Full Text] [Related]
12. The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.
Helpap BG; Bostwick DG; Montironi R
Virchows Arch; 1995; 426(5):425-34. PubMed ID: 7543337
[TBL] [Abstract][Full Text] [Related]
13. Neutral and acid mucins and eosinophil and argyrophil crystalloids in carcinoma and atypical adenomatous hyperplasia of the prostate.
Luna-Moré S; Florez P; Ayala A; Diaz F; Santos A
Pathol Res Pract; 1997; 193(4):291-8. PubMed ID: 9258955
[TBL] [Abstract][Full Text] [Related]
14. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
Qian J; Bostwick DG
Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
[TBL] [Abstract][Full Text] [Related]
15. Small-acinar patterns in the prostate gland with emphasis on atypical adenomatous hyperplasia and small-acinar carcinoma.
Srigley JR
Semin Diagn Pathol; 1988 Aug; 5(3):254-72. PubMed ID: 2459751
[TBL] [Abstract][Full Text] [Related]
16. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate.
Sakr WA; Grignon DJ
Anal Quant Cytol Histol; 1998 Oct; 20(5):417-23. PubMed ID: 9801760
[TBL] [Abstract][Full Text] [Related]
17. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
Rekhi B; Jaswal TS; Arora B
Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
[TBL] [Abstract][Full Text] [Related]
18. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.
McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ; Young RH
Am J Surg Pathol; 2004 Oct; 28(10):1289-98. PubMed ID: 15371944
[TBL] [Abstract][Full Text] [Related]
19. Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma.
Midi A; Tecimer T; Bozkurt S; Ozkan N
Indian J Urol; 2008 Apr; 24(2):169-77. PubMed ID: 19468392
[TBL] [Abstract][Full Text] [Related]
20. Nuclear volume estimates in prostatic atypical adenomatous hyperplasia.
López-Beltrán A; Artacho-Pérula E; Luque-Barona RJ; Roldán-Villalobos R
Anal Quant Cytol Histol; 2000 Dec; 22(6):438-44. PubMed ID: 11147297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
